Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Axonics, Inc. logo — Experience the Difference, Experience Axonics

Axonics, Inc.

Experience the Difference, Experience Axonics

Founded 2013 United States Irvine, United States 703 employees Post-IPO Equity Total: $735.64M Health Care, Medical Devices

General Information

Company Name Axonics, Inc.
Founded Year 2013
Location United States Irvine, United States
Founders / Decision Makers
Team member Team member
Employees 703
Industries Health Care, Medical Devices
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Axonics, Inc.. To contact Axonics, Inc., visit axonics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Axonics, Inc. compare?

A PDF of Axonics, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Axonics, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Axonics, Inc.

Axonics, Inc.:

Axonics, Inc., headquartered in Irvine, California, was founded in 2012 with a mission to improve the quality of life for individuals dealing with bladder and bowel dysfunction, affecting tens of millions globally. The company's flagship products include the Axonics Sacral Neuromodulation System, targeting overactive bladder and fecal incontinence, and the Bulkamid® hydrogel, addressing stress urinary incontinence in women.

Recent investment activity has been notable, with a significant $111.74 million Post-IPO Equity investment secured on 02 August 2022. This infusion of capital underscores investor confidence in Axonics' innovative solutions and market potential.

For more information on Axonics' groundbreaking work, interested parties can visit www.axonics.com and www.bulkamid.com.

Business keywords: Axonics, Neuromodulation, Incontinence, Bladder dysfunction, Bowel dysfunction, Sacral Neuromodulation System, Fecal incontinence, Overactive bladder, Stress urinary incontinence, Medical devices, Medical innovation, California, Global impact, Quality of life improvement

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $111.74M -
02 Aug 2022
Post IPO Equity $201.30M -
14 May 2021
Post IPO Equity $149.50M -
08 May 2020
Post IPO Equity $17.00M -
13 Dec 2019
Post IPO Equity $110.00M -
22 Nov 2019
Series C $40.00M 3
Longitude Capital Gilde Healthcare
Longitude Capital, Gilde Healthcare +1
03 Apr 2018
Series C $20.50M 2
Gilde Healthcare Cormorant Asset Management
Gilde Healthcare, Cormorant Asset Management
06 Jul 2017
Series C $14.50M 5
Advent Life Sciences Legend Capital Andera Partner
Advent Life Sciences, Legend Capital +3
02 May 2017
Series B $38.50M 5
Advent Life Sciences Legend Capital Andera Partner
Advent Life Sciences, Legend Capital +3
22 Dec 2015
Series A $32.60M 4
Aperture Venture Partners Legend Capital Andera Partner
Aperture Venture Partners, Legend Capital +2
25 Mar 2014

Axonics, Inc. Alternatives & Competitors

View All Alternatives
Axonics, Inc. vs
Solace Therapeutics
Solace Therapeutics

Empowering patients with innovative and non-invasive treatments for bladder health, while ensuring c...

Series B
Health Care, Health and Wellness
Compare Axonics, Inc. vs Solace Therapeutics
Axonics, Inc. vs
Tesla Medical s.r.o.
Tesla Medical s.r.o. Czech Republic

We create technology that allows non-invasive treatment of chronic diseases using neuromodulation.

Series A
2 employees
Health Care, Manufacturing
Compare Axonics, Inc. vs Tesla Medical s.r.o.
Axonics, Inc. vs
Caldera Medical
Caldera Medical United States

Caldera's Mission - To Improve the Quality of Life for Women

111 employees
Biotechnology, Health Care
Also compare with: Axonics, Inc. vs inContAlert inContAlert View all alternatives

FAQ About Axonics, Inc.

Experience the Difference, Experience Axonics
Axonics, Inc. was founded in 2013.
Axonics, Inc. is headquartered in Irvine, United States.
Axonics, Inc. operates in Health Care and Medical Devices. Its work centres on Axonics, Neuromodulation, Incontinence and Bladder dysfunction.
Axonics, Inc. has approximately 703 employees.
Axonics, Inc. has completed 10 funding rounds, raising a total of $735.64M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Axonics, Inc. include Solace Therapeutics, Tesla Medical s.r.o., Caldera Medical, ProvenMed® , Elitone by Elidah. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Axonics, Inc. and Solace Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Axonics, Inc., https://bouncewatch.com/company/axonics-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout